Study finds chemotherapy antidote could improve recovery after chemotherapy-induced kidney toxicity

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate (MTX), according to a new study by investigators at Mass General Brigham. Using data from 28 major U.S. cancer centers*, the researchers examined…

Click here to view the original article.